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Background: Post-operative delirium (POD) is a common complication in elderly patients
undergoing surgery, but the underpinning causes are not clear. We hypothesized that
inflammaging, the subclinical low and chronic grade inflammation characteristic of old
people, can contribute to POD onset. Accordingly, we investigated the association of pre-
operative and circulating cytokines in elderly patients (>65 years), admitted for elective and
emergency surgery.
Methods:This is a secondary analysis of a sub-cohort of patients belonging to a previous
large case–control study, where 351 patients were clinically and cognitively thoroughly
characterized, together with the assessment of POD (47 patients) by confusion assess-
ment method and delirium rating scale. Seventy-four pre-operative plasma samples were
selected from a larger bio-bank and they included 37 subjects with POD and 37 with-
out POD. Inflammaging related cytokines, i.e., IL-1β, IL-2, IL-6, IL-8, IL-10, and TNF-α, were
assayed by ELISA in pre-operative blood samples; univariate and multivariable analyses
have been applied to identify cytokines independently associated to POD. Associations
of cytokine levels with functional status, cognitive decline, intra-hospital mortality, and
comorbidity were also analyzed independently of POD onset.
Results: High IL-6 and low-IL-2 levels were significantly associated with POD. After adjust-
ment for potential confounders in multivariate analysis, high level of pre-operative IL-6
was confirmed to be significantly associated with risk of POD onset. High level of IL-6
was also associated with several baseline features (including poor functional status, cogni-
tive impairment, emergency admission, and higher comorbidity burden) and intra-hospital
mortality.
Conclusion: Pre-operative, high-plasma level of IL-6 (≥9 pg/mL) was significantly associ-
ated with POD onset. We propose IL-6 as an additional risk factor of POD onset together
with the previously identified factors. Discovery of all risk factors contributing to POD onset
will permit to improve hospitalized patient management and the decrease of healthcare
cost.
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INTRODUCTION
Post operative delirium (POD) is a common complication pre-
dominantly in old patients undergoing major surgical procedures
Abbreviations: CIRS,cumulative illness rating scale; HADS,hospital anxiety depres-
sion scale; SPMSQ, short portable mental state questionnaire; CAM, confusion
assessment method; DRS, delirium rating scale; ADL, activities of daily living; IADL,
instrumental activities of daily living.
with heavy effects in terms of hospital costs (1). It is associated
with poor outcomes, such as prolonged hospital stays, increased
risk of death, functional and cognitive decline, and a higher rate of
institutionalization. It is well established that delirium incidence
differs in dependence of many factors, among them, the clinical
setting has a prominent role: frequency ranges from 11 to 42% in
the case of medical patients and can reach higher rates in elderly
after hip fracture (2).
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Recently, Inouye indicated the contribution of several predis-
posing and precipitating risk factors and their possible combined
actions in delirium onset (3). Despite an increase of published
articles focused on the identifications of delirium risk factors, the
molecular mechanisms are only partly understood (4) and notably,
the possibility for early identification of subjects who may develop
POD is still to be better defined. Different theories were proposed
to explain delirium pathogenesis; among these, the hypotheses of
neurotransmitters imbalance (5) and inflammatory impairment
(6) are the most widely propagated. Our working hypothesis is
that neuroinflammation leads to POD development as recently
suggested by different authors (7, 8).
It is established that human aging is associated with a chronic
low-level pro-inflammatory status, named by our group inflam-
maging (9, 10) to which the age-related remodeling of the immune
system greatly contributes. Inflammaging has both local and sys-
temic effects and this status may favor, especially when other
predisposing factors are concomitant, an increased risk of age-
related diseases onset (11, 12). The unbalance of pro- and anti-
inflammatory cytokine plasma levels could be a predisposing fac-
tor of POD onset in the pre-operative status of hospital admitted
elderly patients.
In a previous work, we identified a protocol for a first feasibility
study (13) taking into account the hospital unit setting of enrolled
patients (Unit of General, Emergency, and Transplant Surgery; St.
Orsola-Malpighi Hospital, Bologna, Italy). Subsequently, in a sec-
ond work, different variables were evaluated and some risk factors
were identified as follows: (i) age ≥75 years; (ii) cumulative ill-
ness rating scale (CIRS) ≥8, related to comorbidity; (iii) hospital
anxiety depression scale (HADS) ≥15, associated with depres-
sion; (iv) short-portable mental state questionnaire (SPMSQ)≤7,
associated with cognitive decline; (v) deregulated pre-operative
glycemia (14). A large database containing 351 enrolled patients
(out of 1,235 subjects assessed for eligibility) in a case–control
study was realized. The present study aimed to further investigate
predictive factors of POD assessing pre-operative-inflammaging
related-cytokines plasma level.
TNF-α, IL-1beta, IL-2, IL-6, IL-8, and IL-10 cytokines were
determined as secondary analysis in a subgroup of old patients who
were admitted for elective and emergence surgery, as described
previously (14). Furthermore, we also investigated the association
of the above mentioned cytokines independently of POD onset
with age≥75 years, CIRS≥8, HADS≥15, SPMSQ≤7, emergence
surgery, and intra-hospital mortality.
MATERIALS AND METHODS
PATIENT ENROLLMENT
The subjects included in this analysis were male and female of 65+
years old; a sub-cohort belonging to a large case–control study in
which 351 patients were eligible with final purpose to evaluate
POD risk factors. Subjects were admitted at St. Orsola-Malpighi
Hospital (Bologna, Italy) for any kind of emergency or elective
surgery; inclusion and exclusion criteria were previously described
(14) and here briefly reported. Inclusion criteria were patients of
either sex above the age of 65 years, admitted and operated on the
unit for any kind of emergency or elective surgery. Exclusion cri-
teria were patients unable to perform cognitive and psychometric
tests for any reason, including sensory impairment, disorders of
language, and previous diagnosis of dementia. The study protocol
(risk factor evaluation in post-operative delirium; RIFE POD) has
been described previously (13). Ethical approval for the study was
obtained from St. Orsola-Malpighi Hospital Ethical Committee
(Bologna, Italy) and all procedures were followed in accordance
with the Declaration of Helsinki. The presence and severity of POD
among patients enrolled in the study was evaluated through confu-
sion assessment method (CAM: sensitivity of 94–100%, specificity
of 90–95% with high inter-observer agreement) and delirium rat-
ing scale (DRS: sensitivity of 82% and specificity of 94%, cut-off
score of 10) interviews on post-operative days 1, 2, 3, and 6. On
days 4 and 5 after surgery, CAM and DRS were administered only if
hospital personnel or relatives indicated a change in patient behav-
ior, which warranted further investigation. Both instruments are
standardized tools, widely used for delirium recognition and sever-
ity assessment according to diagnostic and statistical manual of
mental disorders (DSM-IV) (15). Forty-seven out of 351 patients
developed POD as previously reported (14).
MEASUREMENTS OF PLASMA CYTOKINES LEVEL
A bio-bank of pre-operative plasma was set up for all the
enrolled patients and 37 out of 47 samples from POD patients
were used in the present work since these samples had never
thawed. Similarly, never-thawed samples from patients who did
not develop POD were randomly selected from the database and
two variables, i.e., gender and age, were tested to be not signifi-
cant (age–gender-matched). Pre-operative plasma cytokines levels
from 74 patients were finally evaluated: 37 without POD and 37
with POD.
Venous blood was withdrawn preoperatively in the morning
of hospital admission day. Plasma was obtained with a centrifu-
gation for 15 min at 1,780× g and −4°C; 300µl aliquots were
stored at −80°C until determination. Cytokine concentrations
(TNF-α, IL-1β, IL-2, IL-6, IL-8,and IL-10) were measured in dupli-
cate by multiplex sandwich ELISA technology (Human Cytokine
Array 1, SearchLight, Aushon Biosystems, Billerica, MA, USA)
according to the manufacturer’s instructions. Final data were
obtained in a blind set up by the operators. An inflammatory
score (IS) was applied, i.e., the sum of the plasma concentration of
pro-inflammatory cytokines (IL-2+ IL-6+ IL-8) divided by anti-
inflammatory cytokines (IL-10), as previously reported by other
authors (16). Associations of cytokine levels with functional sta-
tus, cognitive decline, intra-hospital mortality, and comorbidity
were also analyzed independently of POD onset.
STATISTICAL ANALYSIS
Continuous variables were expressed as mean± SD or±SEM and
categorical variables as percentage. Student unpaired t -test for
continuous variables and Mantel Heantzel Chi-square test for cate-
gorical values were used. Significant variables (p< 0.05), identified
by univariate analysis, were further examined using multivariate
analysis, i.e., logistic regression, in order to evaluate potential inde-
pendent risk factor for POD. To assess the association between
the patient’s characteristics and cytokines level, variables were
dichotomized in two groups and the differences of cytokines lev-
els between the two groups were analyzed with Mann–Whitney
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U test. Statistical analyses were performed using SPSS® software,
version 15.0 (SPSS 15.0 Inc., Chicago, IL, USA).
RESULTS
In this study, we assessed the pre-operative plasma level of 6
cytokines (IL-1β, IL-2, IL-6, IL-8, IL-10, and TNF-α) in 74 patients:
37 POD patients and 37 patients without POD, matched for age
and gender. Baseline characteristics of the two groups (POD and
no-POD) are reported in Table 1 and Table S1 in Supplementary
Material shows the surgical procedures in which 74 patients under-
went. POD patients showed significantly higher medical comor-
bidities, hospital anxiety and depression, and functional decline
compared to patients without POD. Pre-operative assumptions of
benzodiazepines and nitrate-containing drugs were also higher in
patients with POD compared to those without POD. These find-
ings confirmed that the sub-cohort of patients we analyzed was
similar to the previous one. On the other side, some variables, like
hyperglycemia and SPMSQ, did not result significantly different
between the two groups, likely because of the smaller sample size
of the subpopulations here analyzed (14). Likewise, patients who
underwent emergency surgery were not different comparing POD
and no-POD (p= 0.601) groups.
As far as cytokines plasma level is concerned, only samples with
values above the detection limit were considered and more details
are reported in the Table S2 in Supplementary Material. IL-1β and
Table 1 | Baseline characteristics of patients in relation to
post-operative delirium (POD) onset.
POD
(n=37)
No-POD
(n=37)
p-Value
Age, mean±SD 79.2±6.7 76.4±6.7 0.062
Sex ratio (M:F) 20:17 17:20 0.441
CIRS, mean±SD 10.3±5.3 6.8±3.6 0.002
SPMSQ, mean±SD 1.2±1.4 1.1±2.0 0.896
ADL, mean±SD 4.4±2 5.57±1.2 0.003
HADS, mean±SD 17.6±6.6 14.2±6.1 0.024
IADL, mean±SD 5.1±2.3 6.6±2.2 0.006
Emergency surgery, n (%) 28 (75.7) 26 (70.3) 0.601
Nitrate-containing drugs, n (%) 10 (27.0) 3 (8.1) 0.032
Benzodiazepines, n (%) 10 (27.0) 2 (5.4) 0.012
Other hypnotics, n (%) 1 (2.7) 0 (0) 0.345
Antidepressants, n (%) 4 (10.8) 1 (2.7) 0.165
Alcohol abuse, n (%) 0 (0) 0 (0) n.a.
Creatinine (mg/dL), mean±SD 1.7±1.7 1.1±0.4 0.06
Blood glucose (mg/dL), mean±SD 140.0±77.0 117.3±50.0 0.137
Albumin (g/dL), mean±SD 3.1±0.8 4.8±8.8 0.266
Opiate, n (%) 1 (2.7) 0 (0) 0.345
POD, post-operative delirium; CIRS, cumulative illness rating scale; SPMSQ,
short-portable mental status questionnaire; HADS, hospital anxiety and depres-
sion scale; ADL, activities of daily living; IADL, instrumental activities of daily
living; n.a., not assessable.
p-Values were by student unpaired t-test.
p≤0.05 was considered significant (bold characters are reported).
TNF-α, being in the most of cases under the detection limit, were
not further considered.
Baseline plasma levels of IL-6 and IL-2 were significantly differ-
ent between the two groups. IL-6 was higher in POD compared to
no-POD patients (p= 0.021), while IL-2 was significantly lower
in POD with respect to no-POD patients (p= 0.010). We also
observed lower levels of IL-10 and higher levels of IL-8 in POD
compared to control subjects, but these differences were not sig-
nificant (Table 2). An IS (16) showed that the two groups’ results
were significantly different, as reported in Table 2, as POD group
much more inflamed than no-POD group.
As the number of emergency cases was greater in both POD
(28 out of 37) and no-POD (26 out of 37) groups, we performed
further analysis excluding elective cases to check whether the
cytokines level of the two groups were still significantly different.
Both IL-2 and IL-6 persisted to be significant between the groups,
p= 0.041 and p= 0.018, respectively (data not shown).
Subsequently, plasma levels of IL-6 and IL-2 were adjusted
in multivariate analysis for other potential confounders, i.e., age,
CIRS (comorbidity),ADL and IADL (functional abilities, activities
of daily living, instrumental activities of daily living), HADS (hos-
pital anxiety and depression), and pre-operative benzodiazepines
intake. After adjustment for the above mentioned baseline covari-
ates, the association of IL-2 with POD was lost [odds ratio 0.83
(0.63–1.08), p= 0.163] while the association of IL-6 persisted to
be significant [odds ratio 1.1 (1.00–1.20), p= 0.040]. A signif-
icant IL-6 cut off between the two groups POD vs. NO-POD
was ≥9 pg/mL (odds ratio between the two groups: 4.9; 95% of
confidence: 1.6–14.63; p< 0.0005).
Independently of POD onset, high-plasma level of IL-6 was also
associated with poor functional status or ADL<6 (p= 0.030),with
cognitive decline or SPMSQ ≤7 (p= 0.014), emergency admis-
sion (p= 0.023), and higher comorbidity or CIRS≥8 (p= 0.046).
High-plasma level of IL-8 was significantly associated with high
comorbidity (p= 0.009), with poor functional status (p= 0.048)
and age <75 years (p= 0.022). On the other hand, low levels
of IL-2 were associated with emergency admission (p= 0.008),
higher comorbidity (p= 0.050), and low level of IL-10 was found
Table 2 | Plasma cytokines in patients with post-operative delirium
(POD) vs. patients with no-POD.
Cytokine
pg/mL
POD No-POD p-Value
n Median
(25th–75th)
n Median
(25th–75th)
IL-2 35 2.50 (1.40–4.10) 33 4.80 (2.90–6.45) 0.009
IL-6 37 9.00 (2.25–23.65) 34 3.40 (1.85–8.95) 0.021
IL-8 34 6.15 (2.50–23.05) 36 5.00 (2.325–7.75) 0.245
IL-10 29 0.70 (0.25–4.00) 33 0.90 (0.50–1.85) 0.714
I score 27 45.00 (18.5–84.00) 32 18.50 (11.05–28.70) 0.040
I, inflammatory score accordingly to Cerejeira et al. (16); p-values were calcu-
lated using Mann–Whitney U test for non-parametric data. Significant values are
reported in bold characters.
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Table 3 | Correlation between cytokines plasma level and different features independently of POD onset.
Cytokines plasma level (pg/mL)
IL-2 IL-6 IL-8 IL-10
N Mean±SEM p-Value N Mean±SEM p-Value N Mean±SEM p-Value N Mean±SEM p-Value
INTRA-HOSPITAL MORTALITY
Alive 60 5.9±1.0 0.650 64 9.6±3.7 0.001 62 8.9±2.3 0.001 54 4.2±0.3 0.278
Deceased 8 5.4±1.1 7 30.4±2.1 8 28.7±2.2 8 2.6±1.8
CIRS
<8 32 7.8±2.1 0.027 34 7.6±1.9 0.017 34 6.1±1.1 0.022 29 4.8±3.1 0.713
≥8 36 3.8±0.6 37 16.0±3.3 36 17.2±3.5 33 3.6±1.7
Age
<75 years 20 7.9±3.1 0.962 21 13.5±4.9 0.588 22 16.6±4.8 0.255 20 9.3±5.1 0.242
≥75 years 48 4.7±0.7 50 11.4±1.9 48 9.6±1.8 42 1.8±0.4
SPMSQ
>7 57 5.8±1.2 0.887 61 9.4±1.8 0.007 60 10.7±2.1 0.103 51 4.7±1.1 0.787
≤7 11 4.8±1.4 10 27.7±7.0 10 18.4±6.4 11 1.7±0.5
ADL
=6 44 6.9±1.6 0.138 47 9.8±2.3 0.030 47 10.5±2.5 0.620 44 5.1±2.4 0.763
<6 24 3.3±0.4 24 16.3±3.6 23 14.6±3.1 22 1.8±0.5
ADMISSION
Elective 17 11.7±3.7 0.008 20 9.1±3.6 0.026 18 10.8±4.4 0.408 15 5.3±3.7 0.799
Emergency 51 3.9±0.4 51 13.1±2.4 52 12.2±2.2 47 3.8±1.9
Values are reported as mean±SEM; CIRS, cumulative illness rating scale; CIRS ≥8 associated with comorbidity; SPMSQ, short-portable mental status questionnaire;
≥3 associated with cognitive decline; ADL, activities of daily; ADL <6 associated with functional decline; N, number of patients.
p-Values were calculated using Mann–Whitney U test. Significant values are reported in bold characters.
to be associated with age ≥75 years (p= 0.045). These data are
shown in Table 3. Intra-hospital mortality was also evaluated
and high levels of IL-6 (p= 0.001) and IL-8 (p= 0.001) were
found significantly associated with high intra-hospital mortality,
as shown in Table 3.
DISCUSSION
In the present study, we observed increased levels of pro-
inflammatory cytokines (IL-6 and IL-8) in POD patients, while
T cell growth-related and anti-inflammatory cytokines (IL-2 and
IL-10, respectively) were decreased in POD patients. The adopted
IS (16) confirmed the higher level of inflammation in the POD
group. After adjusting for potential confounders, pre-operative
level of IL-6 was confirmed to be significantly associated with
POD, thus, high-IL-6 plasma level, specifically ≥9 pg/mL (using
ELISA multiplex technique), is proposed to be an independent
risk factor of POD onset. We recognize that a limit of this study
was the absence of information related to the use of pre-operative
anti-inflammatory drugs by patients.
Few studies on POD occurrence in older patients investigated
baseline inflammatory markers that can have a predictive value.
Lemstra and co-workers did not find any association between pre-
operative IL-6 and the incidence of delirium after hip surgery (17).
However, this study was carried out in a small number of post-
operative patients. Conversely, an association of IL-6 and IL-8
cytokines with delirium was found in two different works, focused
on medical (18) and surgical (19) patients. In the former, authors
found that IL-6 and IL-8 levels were below the detection limit in
most of control cases when compared with POD patients. In the
latter, van Muster and co-authors, observed highest levels of IL-6
during delirium, whereas highest levels of IL-8 were found in the
days preceding delirium, thus, suggesting that a different timing of
reaching the highest concentration of the two pro-inflammatory
cytokines (20). A recent work showed the high-IL-2 level after
surgery (20), but blood samples were examined only after surgery
and measurements could be affected by surgery stressful event.
In principle, only pre-operative markers can be useful to predict
delirium onset and to deal with it properly.
There is a growing evidence that circulating levels of cytokines
may influence the CNS (21). To this regard, a study showed higher
IL-6 immunoreactivity in the brain of patients with delirium,
suggesting that an association between human brain activity of
microglia, astrocytes, and IL-6 and delirium in old patients (22).
Interestingly, a decreased level of IL-6 was found in pre-operative
cerebrospinal fluid (CSF) from elderly hip fracture patients (23),
thus, suggesting not only a potential role of the molecular up-
taking but also the importance of the anti-inflammatory balance
in the brain. These data also suggest that two microenvironments,
i.e., CSF and peripheral blood could have a different or opposite
concentration of cytokines.
Currently, it is recognized that human aging is characterized
by a chronic, low-grade inflammation, or “inflammaging” and
IL-6, among other cytokines (24, 25), is a key mediator of this
status as recently revised (26). In this work, we found that IL-6
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FIGURE 1 | Pre-, intra-, and post-operative risk factors were evaluated
in univariate and multivariate analyses, depicted as a funnel; the
numbers reported in the figure are referred to the previous work (14). In
this paper, by means of a sub-cohort of 74 patients (37 controls and 37 with
POD), pre-operative IL-6 plasma level (≥9 pg/mL) and age were found to be
independent risk factors together with other pre-operative parameters, i.e.,
CIRS (cumulative illness rating scale), SPMSQ (short-portable mental status
questionnaire), HADS (hospital anxiety and depression scale) showing that
pre-operative variables are the most significant to predict POD onset.
is an independent risk factor of POD onset, thus, making more
robust the theory of inflammation as crucial substrate of the great
majority of age-related pathologies (cancer, osteoarthritis, neu-
rodegeneration including Alzheimer disease and dementia, type
II diabetes among other), syndromes (frailty, depression disor-
ders), and conditions, such as sarcopenia and obesity. Thus, to
better analyze the role and association of pro-anti-inflammatory
cytokines with other parameters, independently of POD, we found
significant higher levels of IL-6 in patients with compromised
functional status, higher comorbidity, cognitive decline, and emer-
gency admission. IL-6 was also found to be positively associated
with intra-hospital mortality, thus, reinforcing the relevance of this
biomarker as one of the predictors of impaired cognitive function,
morbidity, and mortality (27–29).
Likewise, high level of IL-8 was also associated with comor-
bidity and intra-hospital mortality. Increased concentrations of
pro-inflammatory cytokines are believed to contribute to cogni-
tive decline and to predict frailty and mortality (30, 31). Moreover,
low levels of IL-2 were associated with comorbidity and emer-
gency admission. IL-2 may have neuro-regulatory effects, such
as promotion of neuronal survival, stimulation of oligodendro-
cyte proliferation and maturation, hypothalamic-pituitary axis
stimulation, and possibly analgesic properties (32). Therefore,
IL-2 deficiency might favor an impairment or deregulation at
brain level.
In conclusion, the exhaustive identification of POD markers
including genetic markers, as recently published (33), will allow
early recognition of at risk patients. One of the most impor-
tant implications of the present work is the possibility to identify
subjects at high risk of POD onset at the hospitalization time
taking into account the pre-operative IL-6 plasma level together
with the previously identified risk factors (14), i.e., CIRS ≥8,
HADS ≥15, SPMSQ ≤7, age ≥75 years, and glucose abnormal-
ities, summarized in Figure 1. The prediction of POD onset could
highly improve hospitalized patient management, and decreas-
ing of healthcare cost. These effects were recently demonstrated
with the Hospital Elder Life Program, an effective intervention to
prevent delirium in older hospitalized adults, successfully repli-
cated (34). Outcomes include a lower rate of incident delirium;
shorter period of hospitalization; greater satisfaction of patients,
families, and nursing staff; and significantly lower costs for the
hospital. The financial return of the program, estimated at more
than $7.3 million per year during 2008, comprises cost saving from
delirium prevention and revenue generated from freeing up hos-
pital beds (34). Further, the possibility to monitor longitudinally
patients who had developed POD could give an advantage to the
same patients to act promptly with pharmacological therapy or
to counteract as much as possible the development of dementia,
neurodegeneration, or Alzheimer disease with a specific lifestyle
intervention.
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